Creo Medical Group Plc(LSE) CREO

Market Cap£55.58M

Since IPO (2016)-84%

5 Year-94%

1 Year-6%

1 Month-13%

£0.13

+0.16%

+0.00Today

Creo Medical Group Plc last closing stock price
Metric	Price	Date
Last close	GBX 12.38	2026-08-12

Creo Medical Group Plc stock price return by period
Period	Price return	Price at period start	Period start date
1 week	-3.88%	GBX 12.88	2026-08-05
1 month	-13.12%	GBX 14.25	2026-07-13
3 month	+2.06%	GBX 12.13	2026-05-14
Year to date	+25.05%	GBX 9.90	2025-12-31
1 year	-5.71%	GBX 13.13	2025-08-12
3 year	-63.32%	GBX 33.75	2023-08-11
5 year	-93.56%	GBX 192.33	2021-08-13
Since inception	-84.35%	GBX 0.80	2016-12-09

Creo Medical Group Plc Financials at a Glance

Market Cap

£55.58M

Revenue (TTM)

£36.30M

Net Income (TTM)

-£17.10M

EPS (TTM)

£0.01

P/E Ratio

9.67

Dividend

£0.00

Beta (Volatility)

0.07 (Low)

Dividend

£0.00

Beta (Volatility)

0.07 (Low)

Price

£0.13

Volume

182,260

Open

£0.13

Price

£0.13

Volume

182,260

Open

£0.13

Previous Close

£0.12

Daily Range

£0.12 - £0.13

52-Week Range

£0.10 - £0.19

Estimated Earnings Date

Sep 30, 2026

Dividend

£0.00

Beta (Volatility)

0.07 (Low)

Price

£0.13

Volume

182,260

Open

£0.13

Previous Close

£0.12

Daily Range

£0.12 - £0.13

52-Week Range

£0.10 - £0.19

Estimated Earnings Date

Sep 30, 2026

CREO News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Creo Medical Group Plc

Creo Medical Limited is a UK-based company specializing in the development of innovative electrosurgical medical devices for surgical endoscopy applications. Founded in 2003, the company is known for its advanced energy platform, Croma, which powers a range of multi-modal instruments designed to enhance therapeutic interventions.

Products and Services

Croma: An advanced energy platform for surgical endoscopy
Speedboat Inject: A versatile energy instrument for flexible endoscopic procedures
MicroBlate Flex: A flexible microwave ablation device for targeted tissue treatment

Growth Outlook

Recent quarterly revenue reached £3.8 million, indicating potential for growth
Strong product pipeline with innovative devices aimed at expanding market share
Increasing demand for minimally invasive surgical solutions supports long-term growth

Financial Highlights

Trailing twelve-month revenue of £38 million, reflecting a solid market presence
Current ratio of 3.22 suggests strong liquidity and financial health
Net income margin of 0.88% indicates potential for profitability improvement

Creo Medical Limited is positioned in the healthcare sector, focusing on medical devices that cater to the growing demand for minimally invasive surgical procedures. The company's innovative product offerings, such as the Croma platform and its associated instruments, are designed to improve patient outcomes and enhance the efficiency of surgical interventions. The growth outlook appears promising, with recent quarterly revenue figures suggesting a positive trajectory. The company is actively working on expanding its product portfolio, which is expected to capture a larger share of the market. Additionally, the increasing preference for minimally invasive techniques in surgeries aligns well with the company's strategic direction. Financially, Creo Medical Limited has demonstrated resilience, with a current ratio indicating robust liquidity. The trailing twelve-month revenue reflects a solid market presence, while the net income margin suggests room for improvement in profitability. Overall, the company is well-positioned to leverage its innovative technologies and capitalize on the growing demand in the medical device industry.

AI Generated • Aug 2, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

109

CEO

Craig Jonathan Gulliford

Website

www.creomedical.com

Headquarters

Chepstow, WA NP16 5UH, GB

CREO Financials

Key Financial Metrics (TTM)

Gross Margin

31.67%

Operating Margin

-345.00%

Net Income Margin

88.33%

Return on Equity

9.56%

Return on Capital

-38.26%

Return on Assets

8.97%

Earnings Yield

10.34%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

£55.58M

Shares Outstanding

449.14M

Volume

182.26K

Avg. Volume

654.28K

Financials (TTM)

Gross Profit

£16.90M

Operating Income

-£46.20M

EBITDA

-£40.80M

Operating Cash Flow

-£32.60M

Capital Expenditure

-£500.00K

Free Cash Flow

-£33.10M

Cash & ST Invst.

£12.40M

Total Debt

£4.10M

Creo Medical Group Plc Performance Analysis

Creo Medical Group Plc annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2022	2022-12-31	GBP 27,169,000	8.0%
2023	2023-12-31	GBP 4,000,000	-85.3%
2024	2024-12-31	GBP 4,000,000	0.0%
2025	2025-12-31	GBP 6,000,000	50.0%

Creo Medical Group Plc sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q2	2024-06-30	0.7%
Q4	2024-12-31	N/A
Q2	2025-06-30	N/A
Q4	2025-12-31	72.7%

Creo Medical Group Plc annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2022	2022-12-31	GBP -0.14	-0.6%
2023	2023-12-31	GBP -0.07	-51.7%
2024	2024-12-31	GBP -0.08	12.0%
2025	2025-12-31	GBP 0.01	N/A

Creo Medical Group Plc sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q2	2024-06-30	-21.0%
Q4	2024-12-31	N/A
Q2	2025-06-30	N/A
Q4	2025-12-31	-169.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

£3.80M

-75.8%

Gross Profit

£900.00K

-84.5%

Gross Margin

23.68%

N/A

Market Cap

£55.58M

N/A

Market Cap/Employee

£534.43K

N/A

Employees

104

N/A

Net Income

-£11.60M

+0.0%

EBITDA

-£10.20M

+10.5%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Total Cash

£12.40M

-33.0%

Total Debt

£4.10M

-50.6%

Accounts Receivable

£6.90M

-12.7%

Inventory

£2.50M

-69.1%

Long Term Debt

£1.80M

-65.4%

Short Term Debt

£2.30M

-25.8%

Return on Assets

8.97%

N/A

Return on Invested Capital

-39.96%

N/A

Free Cash Flow

-£34.20M

-375.0%

Operating Cash Flow

-£34.20M

-434.4%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

KOO.LKooth plc

KOO.LKooth plc£1.46-2.67%

HVO.LhVIVO plc

HVO.LhVIVO plc£0.07+0.60%

HEMO.LHemogenyx Pharmaceuticals Plc

HEMO.LHemogenyx Pharmaceuticals Plc£6.22-2.05%

NCYT.LNovacyt S.A.

NCYT.LNovacyt S.A.£0.45+0.67%

IMM.LImmuPharma PLC

IMM.LImmuPharma PLC£0.04+1.54%

IHC.LInspiration Healthcare Group plc

IHC.LInspiration Healthcare Group plc£0.19+0.00%

RENX.LRenalytix Plc

RENX.LRenalytix Plc£0.04-4.05%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

ONDSOndas

ONDSOndas$9.77+0.00%

SPCXSpace Exploration Technologies

SPCXSpace Exploration Technologies$146.15+0.10%

NOKNokia

NOKNokia$10.32+0.09%

MUUDirexion Shares ETF Trust - Direxion Daily Mu Bull 2x ETF

MUUDirexion Shares ETF Trust - Direxion Daily Mu Bull 2x ETF$28.53+0.10%

SMCISuper Micro Computer

SMCISuper Micro Computer$37.61+0.19%

INTCIntel

INTCIntel$100.95+0.03%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$74.60+0.02%

Questions About CREO

What is the current price of Creo Medical Group Plc?

Creo Medical Group Plc is trading at £0.13 per share.

What is the 52-week range for Creo Medical Group Plc?

Over the past 52 weeks, Creo Medical Group Plc has traded between £0.10 and £0.19.

How much debt does Creo Medical Group Plc have?

As of the most recent reporting period, Creo Medical Group Plc reported total debt of £4.10M.

How much cash does Creo Medical Group Plc have on hand?

Creo Medical Group Plc reported £12.40M in cash and cash equivalents in its most recent financial results.

What is Creo Medical Group Plc’s dividend yield?

Creo Medical Group Plc does not currently have a dividend yield.

Creo Medical Group Plc(LSE) CREO

Creo Medical Group Plc Financials at a Glance

CREO News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Creo Medical Group Plc

CREO Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Creo Medical Group Plc Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About CREO

What is the current price of Creo Medical Group Plc?

What is the 52-week range for Creo Medical Group Plc?

How much debt does Creo Medical Group Plc have?

How much cash does Creo Medical Group Plc have on hand?

What is Creo Medical Group Plc’s dividend yield?

Premium Investing Services